Cho YS, et al. - In participants with mild, moderate and moderately severe hearing impairment, researchers assessed the clinical effectiveness of a personal sound amplification product (PSAP) by comparing its performance with that of basic hearing aid (HA) and a premium HA. There were no differences between PSAP, basic HA, and premium HA for speech perception, sound quality, listening effort, and user preference in this cohort study of 56 adults for those with mild and moderate hearing loss. However, the premium HA had better performance over most tests for the group with moderately severe hearing loss, and 70% of these participants preferred to use the premium HA. The outcomes show that basic and premium HAs in patients with mild to moderate hearing impairment were not superior to PSAP, which suggests that PSAPs in these patient populations could be used as an alternative to HAs. However, if hearing loss is more severe, then HAs should be considered as an option for managing hearing loss, particularly premium HAs.